Huaren Pharmaceutical Co., Ltd. Stock: price and insider trades · China
华仁药业
No insider purchase over the last 90 days. The latest, by 杨效东, was filed 06 Feb 2024.
Huaren Pharmaceutical Co., Ltd.: what insiders have been doing
Every trade that managers of Huaren Pharmaceutical Co., Ltd. disclose to SSE / SZSE (CSRC) is tracked on this page. The company sits in the Health Care sector. Nothing new has been filed by managers of Huaren Pharmaceutical Co., Ltd. in twelve months, the latest record being from 6 February 2024.
The full history, which starts in 2021, counts 9 purchases against no sales.
In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
Since the insiders bought
- +3.6%Entry CN¥3.08 · Close at T+365 CN¥3.19
- -10.5%Entry CN¥4.38 · Close at T+365 CN¥3.92
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 10,000 shares0.7% of flowA股XSHESZSE:173000007310430660Canonical exit: 6 May 2024 (T+90)
- 10,000 shares0.9% of flowA股XSHESZSE:173000005476543360Canonical exit: 25 Jul 2022 (T+90)
- 120,000 shares10.8% of flowA股XSHESZSE:173000005470390200Canonical exit: 24 Jul 2022 (T+90)
- 40,000 shares4.0% of flowA股XSHESZSE:173000004737186000Canonical exit: 25 Nov 2021 (T+90)
- 20,000 shares2.0% of flowA股XSHESZSE:173000004552150700Canonical exit: 6 Oct 2021 (T+90)
- 30,000 shares100.0% of flowA股XSHESZSE:173000004512521800Canonical exit: 21 Sept 2021 (T+90)
- 20,000 shares2.0% of flowA股XSHESZSE:173000004497358720Canonical exit: 15 Sept 2021 (T+90)
- 790,000 shares78.6% of flowA股XSHESZSE:173000004486746800Canonical exit: 9 Sept 2021 (T+90)
- 10,000 shares1.0% of flowA股XSHESZSE:173000004478425860Canonical exit: 8 Sept 2021 (T+90)
9 of 9 declarations
About Huaren Pharmaceutical Co., Ltd.
Hua Ren Pharmaceutical is a company in the health and pharmaceutical sector, listed on the XSHE market. It focuses on the development and production of innovative drugs.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
